Peptide record

TPDB44475

Antiviral standard
21 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB44475
Antiviral
Anti-infective peptides
AI4AVP AVPpred-BWR Peptipedia
standard
No
A 21-aa standard-residue antiviral peptide sequence curated from AI4AVP, AVPpred-BWR, and Peptipedia, with an available 3D structural model.
Sequence
GHKARVLAEAMSQVTNPATIM
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C94H161N29O29S2
DCFWY
A
2225.61
10.09
3
1
10
+1
1.04
0.067
83.81
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
5
Residue Composition
number
4
A
1
R
1
N
0
D
0
C
1
E
1
Q
1
G
1
H
1
I
1
L
1
K
2
M
0
F
1
P
1
S
2
T
0
W
0
Y
2
V
Amino Acid Distribution
A: 4 R: 1 N: 1 D: 0 C: 0 E: 1 Q: 1 G: 1 H: 1 I: 1 L: 1 K: 1 M: 2 F: 0 P: 1 S: 1 T: 2 W: 0 Y: 0 V: 2
Chemical Descriptors
21 reviewed residue count
C94H161N29O29S2 sequence-only estimate (linear, free termini)
2225.61 sequence-only estimate (linear, free termini)
10.09 sequence-only estimate (linear, free termini)
+1 sequence-only estimate (linear, free termini)
1.04 sequence-only estimate (linear, free termini)
0.067 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

NA